Intermediary

The D2C Market has expanded steadily, driven by rising Internet and smartphone penetration, an expanding population, and the expansion of online retailers and payment methods: Ken Analysis: Ken Research

Retrieved on: 
Friday, July 22, 2022

The market growth was supported by the increase in total smartphone penetration, growth in online shoppers and rise in youth population.

Key Points: 
  • The market growth was supported by the increase in total smartphone penetration, growth in online shoppers and rise in youth population.
  • The market is currently placed in the growth stage owing to the increasing penetration of online retail sales during 2019.
  • The competition in Taiwan online retail market has increased over the years leading to the increasing number of online retail websites in Taiwan.
  • The online retail market in Taiwan is expected to witness a single-digit growth rate in the forecast period 2018-2023E.

The D2C Market has expanded steadily, driven by rising Internet and smartphone penetration, an expanding population, and the expansion of online retailers and payment methods: Ken Analysis: Ken Research

Retrieved on: 
Friday, July 22, 2022

The market growth was supported by the increase in total smartphone penetration, growth in online shoppers and rise in youth population.

Key Points: 
  • The market growth was supported by the increase in total smartphone penetration, growth in online shoppers and rise in youth population.
  • The market is currently placed in the growth stage owing to the increasing penetration of online retail sales during 2019.
  • The competition in Taiwan online retail market has increased over the years leading to the increasing number of online retail websites in Taiwan.
  • The online retail market in Taiwan is expected to witness a single-digit growth rate in the forecast period 2018-2023E.

ACI Worldwide and IR Partnership Unlocks Insights Through Real-Time Enterprise Transaction Monitoring

Retrieved on: 
Thursday, July 21, 2022

Part of the ACI Enterprise Payments Platform , ACI Payments Monitoring powered by IR Transact gives banks and financial institutions visibility into the health of their systems and status of payments in real time covering high-value and low-value real-time payments, as well as card payments.

Key Points: 
  • Part of the ACI Enterprise Payments Platform , ACI Payments Monitoring powered by IR Transact gives banks and financial institutions visibility into the health of their systems and status of payments in real time covering high-value and low-value real-time payments, as well as card payments.
  • The announcement of full enterprise monitoring capabilities follows more than two decades of successful partnership between ACI and IR.
  • "By extending our long-standing and successful partnership with IR, we have also further enriched our real-time analytical capabilities, delivering comprehensive and actionable business insights."
  • "Through our expanded partnership with ACI, banks and financial institutions benefit from real-time monitoring that helps them glean actionable insights on a single pane of glass.

ACI Worldwide and IR Partnership Unlocks Insights Through Real-Time Enterprise Transaction Monitoring

Retrieved on: 
Thursday, July 21, 2022

Part of the ACI Enterprise Payments Platform , ACI Payments Monitoring powered by IR Transact gives banks and financial institutions visibility into the health of their systems and status of payments in real time covering high-value and low-value real-time payments, as well as card payments.

Key Points: 
  • Part of the ACI Enterprise Payments Platform , ACI Payments Monitoring powered by IR Transact gives banks and financial institutions visibility into the health of their systems and status of payments in real time covering high-value and low-value real-time payments, as well as card payments.
  • The announcement of full enterprise monitoring capabilities follows more than two decades of successful partnership between ACI and IR.
  • "By extending our long-standing and successful partnership with IR, we have also further enriched our real-time analytical capabilities, delivering comprehensive and actionable business insights."
  • "Through our expanded partnership with ACI, banks and financial institutions benefit from real-time monitoring that helps them glean actionable insights on a single pane of glass.

Nabriva Therapeutics Expands XENLETA® (lefamulin) Presence with Exclusive Agreement with Er-Kim Pharmaceuticals

Retrieved on: 
Monday, July 18, 2022

Nabriva will be the exclusive supplier of XENLETA to Er-Kim.

Key Points: 
  • Nabriva will be the exclusive supplier of XENLETA to Er-Kim.
  • Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections.
  • Nabriva Therapeutics received U.S. Food and Drug Administration approval for XENLETA (lefamulin injection, lefamulin tablets), the first systemic pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP).
  • XENLETA (lefamulin) is a first-in-class semi-synthetic pleuromutilin antibiotic for systemic administration in humans discovered and developed by the Nabriva Therapeutics team.

Quoin Pharmaceuticals and Endo Ventures Limited Enter Into Exclusive Distribution and Supply Agreements

Retrieved on: 
Friday, July 15, 2022

Under the terms of the License and Distribution Agreement, Endo Ventures has the exclusive right, which was sublicensed to its affiliate, Paladin Labs Inc., to commercialize QRX003 in Canada, upon the receipt of the regulatory approvals.

Key Points: 
  • Under the terms of the License and Distribution Agreement, Endo Ventures has the exclusive right, which was sublicensed to its affiliate, Paladin Labs Inc., to commercialize QRX003 in Canada, upon the receipt of the regulatory approvals.
  • Under the Supply Agreement, Quoin is obligated to manufacture and supply the product to Endo Ventures.
  • Last month, Quoin announced it had secured an exclusive license and distribution agreement with WinHealth Investment (HK) Limited, covering greater China, including Hong Kong, Macau and Taiwan.
  • Quoin Pharmaceuticals Ltd. is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases.

Nearwater Capital Announces Appointment of Gary Barnett and John Willian to the Board of Directors of Nearwater Capital Markets, Limited.

Retrieved on: 
Monday, July 11, 2022

DUBLIN, July 10, 2022 /PRNewswire/ -- Nearwater Capital today announced the formal appointment of Gary Barnett and John Willian as non-executive directors to the board of Nearwater Capital Markets, Limited (Nearwater Capital Markets).

Key Points: 
  • DUBLIN, July 10, 2022 /PRNewswire/ -- Nearwater Capital today announced the formal appointment of Gary Barnett and John Willian as non-executive directors to the board of Nearwater Capital Markets, Limited (Nearwater Capital Markets).
  • Mr. Barnett has an extensive background in swap dealer and security-based swap dealer policy, regulation and oversight.
  • Nearwater Capital Markets was established and capitalized in 2021 in Ireland and is owned and operated by Nearwater Capital.
  • Nearwater Capital, LP ("Nearwater Capital') is a specialty finance company that was established in 2017.

One80 Intermediaries Deepens Affinity Business With Acquisition of SelmanCo

Retrieved on: 
Wednesday, July 6, 2022

One80 Intermediaries (One80), a specialty insurance broker headquartered in Boston, today announced the acquisition of SelmanCo, a leading third-party administrator and broker offering life, supplemental health and related products and services to associations, credit unions, banks, employers and insurance companies.

Key Points: 
  • One80 Intermediaries (One80), a specialty insurance broker headquartered in Boston, today announced the acquisition of SelmanCo, a leading third-party administrator and broker offering life, supplemental health and related products and services to associations, credit unions, banks, employers and insurance companies.
  • SelmanCo has been in business for over 40 years and operates throughout the U.S. and Canada with headquarters in Cleveland, Ohio.
  • SelmanCo provides insurance services to more than 1.3 million customers, and serves over 800 financial institutions, 2,100 employers and 70 affinity groups.
  • One80 Intermediaries is excited to further expand our presence in the affinity market.

IceCure Medical, Shanghai Medtronic & Turing Medical Sign Distribution Agreement in Mainland China

Retrieved on: 
Monday, June 13, 2022

While Shanghai Medtronic conducts all marketing, sales, and certain professional training, Turing will be responsible for the import, installation, and after-sales service of IceSense3 systems in mainland China.

Key Points: 
  • While Shanghai Medtronic conducts all marketing, sales, and certain professional training, Turing will be responsible for the import, installation, and after-sales service of IceSense3 systems in mainland China.
  • "Shanghai Medtronic and Turing are ideal partners for us in mainland China where cryoblation technology currently has minimal market penetration.
  • Pursuant to the Distribution Agreement, IceCure Shanghai will sell the Products to Turing, which will import the Products from Israel to mainland China, and resell them to Shanghai Medtronic.
  • If IceCure Shanghai fails to obtain the Regulatory Approvals for the Cryoprobes by such time, Shanghai Medtronic has the right to terminate the Distribution Agreement.

First futures exchange aimed at health care economy has filed for regulatory approval

Retrieved on: 
Wednesday, June 1, 2022

CHICAGO, June 1, 2022 /PRNewswire/ -- Intelligent Medicine Exchange (IMX)™ today announced its plans to launch the first financial exchange focused on the health care economy. IMX has filed for regulatory approval with the U.S. Commodity Futures Trading Commission (CFTC) to be a Designated Contract Market (DCM) – a futures exchange focused on contracts that will enable individual and institutional market participants to manage risk and invest in multiple components of the health care ecosystem.

Key Points: 
  • Intelligent Medicine Exchange (IMX) to offer new risk management, investing tools based on underlying health care data
    CHICAGO, June 1, 2022 /PRNewswire/ -- Intelligent Medicine Exchange (IMX) today announced its plans to launch the first financial exchange focused on the health care economy.
  • IMX has filed for regulatory approval with the U.S. Commodity Futures Trading Commission (CFTC) to be a Designated Contract Market (DCM) a futures exchange focused on contracts that will enable individual and institutional market participants to manage risk and invest in multiple components of the health care ecosystem.
  • Health care represents nearly 20% of the U.S. gross domestic product (GDP), but there is currently no dedicated derivatives market to hedge risk.
  • The company, based in Chicago, has filed for regulatory approval with the U.S. Commodity Futures Trading Commission (CFTC) to be a Designated Contract Market (DCM).